EFFECTS OF BROMOCRIPTINE MESYLATE ON HOMOCYSTEINE AND HIGH-SENSITIVITY C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NIAFAR MITRA; POURAFKARI LEILI; SHAHSAVARINIA KAVUS; MILANCHIAN NUSHIN; NIAFAR FARHAD; NADER NADER D.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Cardiovascular and Thoracic Research Year:2016 | Volume:8 | Issue:1 Page(s): 8-12

Download Full-Text

View:

280

Download:

151

Cites:

Information Journal Paper

Title

EFFECTS OF BROMOCRIPTINE MESYLATE ON HOMOCYSTEINE AND HIGH-SENSITIVITY C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS

Author(s)

Keywords

HOMOCYSTEINE

BROMOCRIPTINE

CRP

Abstract

Introduction: Quick release BROMOCRIPTINE (BROM-QR), currently approved for glycemic control, reduces the risk of cardiovascular events in adults with type-2 diabetes mellitus (T2DM). This study evaluates the effect of BROM-QR on HOMOCYSTEINE (HOMC) and high sensitive C-reactive protein (hs-CRP), the biochemical markers of coronary atherosclerosis/inflammation, in patients with uncontrolled T2DM.Methods: In this non-randomized, before-and-after clinical trial, patients with uncontrolled T2DM on stable doses of two oral hypoglycemic agents received BROM-QR for 6 months. The change in serum concentrations of HOMC was the primary endpoint. Anthropometric measurements such as body mass index (BMI) and waist circumference were measured at the baseline and at the completion of treatment along with fasting plasma glucose (FPG), HbA1c, total cholesterol, triglyceride, creatinine and hs-CRP. Multivariate regression analysis was performed to identify factors associated with changes in the levels of HOMC.Results: In 64 patients (46 completed 6 months of treatment), age was 55±7 years and the duration of T2DM was 8.0±4.4 years. On enrollment, mean HbA1c, FPG, hs-CRP and HOMC levels were 9.0±1.3 percent, 184±42 mg/dL, 3.8±3.4 mg/dl and 10.8±6.2 micromole/L; respectively. Mean decrease of 0.7±1.1 percent for HbA1c (P=0.001) and 22±44 mg/dL for FPG was observed (P=0.002). HOMC levels decreased to 8.5±5.2 micromole/L (P=0.011) while hs-CRP levels remained unchanged at 3.7±2.9 mg/dL (P=0.835).Conclusion: While HOMC and HbA1c levels decreased significantly after 6 months of treatment with BROM-QR in patients with T2DM, serum levels of hs-CRP, total cholesterol and triglyceride did not significantly change.

Cites

No record.

References

No record.

Cite

APA: Copy

NIAFAR, MITRA, POURAFKARI, LEILI, SHAHSAVARINIA, KAVUS, MILANCHIAN, NUSHIN, NIAFAR, FARHAD, & NADER, NADER D.. (2016). EFFECTS OF BROMOCRIPTINE MESYLATE ON HOMOCYSTEINE AND HIGH-SENSITIVITY C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS. JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 8(1), 8-12. SID. https://sid.ir/paper/314920/en

Vancouver: Copy

NIAFAR MITRA, POURAFKARI LEILI, SHAHSAVARINIA KAVUS, MILANCHIAN NUSHIN, NIAFAR FARHAD, NADER NADER D.. EFFECTS OF BROMOCRIPTINE MESYLATE ON HOMOCYSTEINE AND HIGH-SENSITIVITY C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS. JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH[Internet]. 2016;8(1):8-12. Available from: https://sid.ir/paper/314920/en

IEEE: Copy

MITRA NIAFAR, LEILI POURAFKARI, KAVUS SHAHSAVARINIA, NUSHIN MILANCHIAN, FARHAD NIAFAR, and NADER D. NADER, “EFFECTS OF BROMOCRIPTINE MESYLATE ON HOMOCYSTEINE AND HIGH-SENSITIVITY C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS,” JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, vol. 8, no. 1, pp. 8–12, 2016, [Online]. Available: https://sid.ir/paper/314920/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops